The global sanger sequencing services market was valued at USD 1.6 billion in 2019 and is expected to reach USD 3.4 billion by 2027, growing at a CAGR of 10.1% from 2020 to 2027, according to latest study by Emergen Research.
The global sanger sequencing services market was valued at USD 1.6 billion in 2019 and is expected to reach USD 3.4 billion by 2027, growing at a CAGR of 10.1% from 2020 to 2027, according to latest study by Emergen Research. The Sanger sequencing services market is driven by the increasing demand for new and innovative sequencing services. The key players in this market are focused on providing innovative and customized solutions to their clients. Moreover, service providers are offering competitive prices for their services, which is expected to fuel the growth of this market.
Sanger sequencing is a chain termination method of DNA sequencing that employs dideoxynucleotides. It is also known as the dideoxy method or the chain termination method. Sanger sequencing services are used in a variety of applications, including genome mapping, DNA fingerprinting, and diagnosis of genetic disorders.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/789
The growth of the global sanger sequencing services market is primarily driven by the increasing demand for genome sequencing and personalized medicine. In addition, the emergence of next-generation sequencing (NGS) and the increasing use of DNA sequencing in drug discovery and development are expected to provide significant growth opportunities for market expansion. However, the high cost of sanger sequencing services is expected to restraint market growth during the forecast period.
Technological advancements have resulted in the development of new techniques for DNA sequencing. Sanger sequencing is one of the most popular methods used for sequencing genomes and other long stretches of DNA. The method was developed by Frederick Sanger and his colleagues in 1977 and has been widely used in research laboratories across the globe. However, with the advent of newer technologies such as next-generation sequencing (NGS), the demand for Sanger sequencing services is expected to decline in the coming years.
The demand for Sanger’s sequencing services has surged significantly due to the outbreak of the COVID-19 pandemic. Sanger sequencing is considered to be one of the most accurate methods for determining the nucleotide sequence of DNA and RNA, which makes it an essential tool for understanding the novel coronavirus. The technique has been used extensively to study the genomes of various strains of the virus, including those responsible for the pandemic. In addition, Sanger sequencing is also being used to develop diagnostic tests and vaccines for COVID-19.
The sudden increase in demand for Sanger sequencing services has resulted in a shortage of the reagents and enzymes required for the procedure. This has led to a significant increase in the price of these chemicals. However, the demand for Sanger sequencing services is expected to remain high in the near future, as the pandemic continues to spread.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/sanger-sequencing-services-market
Some Key Highlights in the Report:
- Key companies in the market include Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, ceMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Inc., Nucleics, SciGenom Labs Pvt. Ltd.,and Microsynth A.G. Inc.
- In May 2021, genome sequencing service provider Macrogen Europe and Australian genomics services company Genomix4u announced a strategic partnership to provide Sanger sequencing services in Europe and Australia. Under the partnership, Macrogen will offer Sanger sequencing services to European customers through its Next-Generation Sequencing Center of Excellence in Amsterdam, Netherlands. In addition, Genomix4u will be the exclusive provider of Sanger sequencing services in Australia. The partnership between the two companies will help them to expand their customer base and offer Sanger sequencing services at a competitive price.
- Pharmaceutical and biotechnology segment revenue to expand at a rapid revenue CAGR over the forecast period due to the rising demand for personalized medicine. The genomic sequencing services enable the development of bespoke treatment plans as per the individual’s DNA that can help in early diagnosis and improve patient outcomes.
- Biomarkers and cancer segment is expected to account for largest revenue share over the forecast period owing to increasing use of DNA as a biomarker in cancer diagnosis and treatment. Cancer is the second most common disease globally after cardiovascular diseases, with an estimated 18 million new cases and 9.6 million deaths in 2018. According to the World Health Organization (WHO), one out of six deaths globally is due to cancer and it is anticipated to become the leading cause of death by 2020.
- On the basis of application, the market is categorized into basic research, drug discovery & development, diagnostics, and forensics. Of these, diagnostics segment led the overall market in 2016 owing to increased demand for this sequencing services from molecular diagnostic laboratories and hospitals. However, forensics segment is projected to grow at the highest CAGR over the forecast period owing to increasing use of these services for criminal investigation purposes.
- On the basis of end user, the market is classified into pharmaceutical & biotechnology companies, academic & government research institutes, and hospitals & molecular diagnostic laboratories. Of these, pharmaceutical & biotechnology companies segment dominated the overall market in 2016 owing to large number of applications in this sector. However, academic & government research institutes segment is projected to grow at the highest CAGR over the forecast period owing to increasing government funding for genomics research.
- Geographically, the global sanger sequencing services market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market during the forecast period due to the presence of a large number of sequencing service providers in the region. Also, the region has a well-developed infrastructure for genomic research.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/789
For the purpose of this report, Emergen Research has segmented the global Sanger sequencing services market on the basis of application, end-use, and region:
Application Outlook (Revenue, USD Billion; 2018-2028)
- Diagnostics
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/789
Explore More Reports Emergen Research:
Feminine Hygiene Products Market
Electrosurgical Devices Market
Surface Treatment Chemicals Market
Industrial Maintenance Coatings Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Published Titles Smart Cities Market | Smart Learning Market
Trending Titles Humanoid Robot Market | Incident Response Market